1. Home
  2. TENX vs HYFM Comparison

TENX vs HYFM Comparison

Compare TENX & HYFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • HYFM
  • Stock Information
  • Founded
  • TENX 1967
  • HYFM 1977
  • Country
  • TENX United States
  • HYFM United States
  • Employees
  • TENX N/A
  • HYFM N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • HYFM Industrial Machinery/Components
  • Sector
  • TENX Health Care
  • HYFM Industrials
  • Exchange
  • TENX Nasdaq
  • HYFM Nasdaq
  • Market Cap
  • TENX 21.7M
  • HYFM 22.8M
  • IPO Year
  • TENX N/A
  • HYFM 2020
  • Fundamental
  • Price
  • TENX $6.30
  • HYFM $2.15
  • Analyst Decision
  • TENX Strong Buy
  • HYFM Hold
  • Analyst Count
  • TENX 3
  • HYFM 2
  • Target Price
  • TENX $16.00
  • HYFM $7.00
  • AVG Volume (30 Days)
  • TENX 20.7K
  • HYFM 26.6K
  • Earning Date
  • TENX 05-13-2025
  • HYFM 05-13-2025
  • Dividend Yield
  • TENX N/A
  • HYFM N/A
  • EPS Growth
  • TENX N/A
  • HYFM N/A
  • EPS
  • TENX N/A
  • HYFM N/A
  • Revenue
  • TENX N/A
  • HYFM $190,288,000.00
  • Revenue This Year
  • TENX N/A
  • HYFM $5.45
  • Revenue Next Year
  • TENX N/A
  • HYFM $5.33
  • P/E Ratio
  • TENX N/A
  • HYFM N/A
  • Revenue Growth
  • TENX N/A
  • HYFM N/A
  • 52 Week Low
  • TENX $2.77
  • HYFM $1.83
  • 52 Week High
  • TENX $7.89
  • HYFM $12.00
  • Technical
  • Relative Strength Index (RSI)
  • TENX 49.26
  • HYFM 23.53
  • Support Level
  • TENX $6.00
  • HYFM $1.83
  • Resistance Level
  • TENX $6.76
  • HYFM $2.32
  • Average True Range (ATR)
  • TENX 0.40
  • HYFM 0.24
  • MACD
  • TENX 0.02
  • HYFM 0.01
  • Stochastic Oscillator
  • TENX 39.47
  • HYFM 17.85

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About HYFM Hydrofarm Holdings Group Inc.

Hydrofarm Holdings Group Inc is a distributor and manufacturer of agriculture equipment and supplies. Some of its products includes lighting solutions, growing media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies sold under proprietary, exclusive/preferred brands, or non-exclusive/distributed brands. The business is organized into two operating segments, the U.S. and Canada.

Share on Social Networks: